A pilot study undertaken by Northumbria Trust to investigate the effects of octenisan® wash lotion for pre-operative washing, following knee and hip replacement surgery, has seen a successful reduction off SSI’s and significant cost savings.
The Journal of Infection Control published an article following a pilot study undertaken by Northumbria Trust. The study investigates the effect of screening and decontamination, when octenisan® wash lotion is prescribed for pre-operative washing, following knee and hip replacement surgery.
The study reports that the MSSA screening and eradication protocol was effective at reducing rates of MSSA following knee and hip replacement surgery. Infection data was compared with a control group and the study was deemed a success after a significant reduction of surgical site infections from 0.75% to 0.25% and cost savings of approximately £1,031,039.
A follow-up study has begun to scale up this successful initiative across a further 40 Trusts. The study supports the NHS Improvement’s strategy ‘Getting It Right First Time’ and aims to reduce complications that arise from surgery. Each Trust will implement the protocol for approximately 6 months and it is expected that a total of 30,000 patients will receive the intervention. The stated aim is to change surgical practice across the NHS by 2020.
Here is a link to the study, that can accessed and downloaded by any healthcare professional: